The US Food and Drug Administration (FDA) has been urged to amend regulations preventing generic drug manufacturers from updating labelling, allowing them to warn patients about associated drug risks.

FDA regulations currently prevent makers of generic drugs to update labels even if they are made aware of an unstated risk to the consumer, as they must remain identical to the original brand-name product.

However, manufacturers of brand-name medications are entitled to alter their labels without FDA approval, a rule that advocacy group Public Citizen has labelled as illogical.

The disparity was highlighted in the US Supreme Court in June 2011 during the case of Pliva vs Mensing.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData